Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

BACKGROUND: The efficacy of inhaled salmeterol plus fluticasone propionate (SFC) in patients with severe or very severe COPD is well documented. However, there are only limited data about the influence of GOLD severity staging on the effectiveness of SFC, particularly in patients with milder disease...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jenkins, Christine R, Jones, Paul W, Calverley, Peter MA, Celli, Bartolome, Anderson, Julie A, Ferguson, Gary T, Yates, Julie C, Willits, Lisa R, Vestbo, Jörgen
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2009
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2714501/
https://ncbi.nlm.nih.gov/pubmed/19566934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-10-59
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge